Mengzhao Z. Wang
Peking Union Medical College Hospital, Peking Union Medical College
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 371 publications
Delayed Occurrence of Lung Cancer Leptomeningeal Metastasis and Era-Associated Post-LM Survival: A 14-Year Single-Center Cohort Study.
Journal: Thoracic cancer
Published: July 19, 2026
Sutetinib for Patients with Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase IIb Trial.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: June 16, 2026
Decision-Support Framework for Nutritional Risk in Small Cell Lung Cancer: A Time-Series Model Using Imputation Strategies for Incomplete Clinical Data.
Journal: Thoracic cancer
Published: June 12, 2026
First-Line Sunvozertinib in NSCLC with EGFR Exon 20 Insertion Mutations.
Journal: The New England journal of medicine
Published: May 29, 2026
First-Line Sunvozertinib in NSCLC with EGFR Exon 20 Insertion Mutations.
Journal: The New England journal of medicine
Published: May 29, 2026
International Consensus on Severe Lung Cancer-The Second Edition.
Journal: Translational lung cancer research
Published: March 21, 2026
Antifungal Prophylaxis and Preemptive Therapy to Prevent COVID-19-Associated Pulmonary Aspergillosis in Patients Requiring Advanced Respiratory Support: A Real-World Cohort Study in China.
Journal: Respiratory medicine
Published: February 26, 2026
Elevated baseline C-reactive protein predicts poorer survival in lung cancer: a 22-year retrospective cohort study.
Journal: Translational lung cancer research
Published: January 27, 2026
Plain language summary: comparing ivonescimab with pembrolizumab in people with PD-L1-positive non-small cell lung cancer in the HARMONi-2 study.
Journal: Future oncology (London, England)
Published: December 29, 2025
Sensitivity of different epidermal growth factor receptor (EGFR) exon 19 deletion subtypes to first-line osimertinib in Chinese non-small cell lung cancer patients.
Journal: BMC cancer
Published: November 13, 2025
Durvalumab Consolidation Treatment Following Concurrent Chemoradiotherapy in Limited-Stage SCLC: ADRIATIC China Subgroup Analysis.
Journal: JTO clinical and research reports
Published: November 07, 2025
Divergent Tumor Immune Microenvironment and Response to Neoadjuvant Chemoimmunotherapy in Resectable Non-Small Cell Lung Cancer: A Single-Arm Phase II Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 05, 2025
Last Updated: 09/26/2026